$PIII

P3 Health (PIII) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, Aug. 14, 2025 at 4:30 p.m. ETChief Executive Officer - Aric CoffmanContinue reading ...

Original reporting
Motley Fool · Motley Fool Transcribing
Published Aug 14, 2025, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
P3 Health (PIII) Q2 2025 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PIIINeutralLow
01

Why it matters

The transcript indicates stability, with no immediate red flags or major catalysts, suggesting limited short-term trading opportunities.

02

Market read

The news has low immediate trading relevance but offers a snapshot of the company's current financial state.

03

What to watch

Potential upcoming product launches or regulatory changes not discussed in the transcript could influence future performance.

Timing: Long-term

Background

P3 Health's Q2 2025 earnings call provides insights into its financial health amid ongoing industry developments.

Company-level read

Ticker impact

$PIIINeutralMedium confidence
Context

Primary focus of the earnings call transcript; relevant for assessing company-specific developments.

Expected impact

Likely minimal short-term price movement; potential for slight upward drift if positive sentiment persists.

Evidence & confidence

The transcript reflects steady performance without major catalysts, but positive sentiment could support minor gains.

Market effects

Limited; the focus remains on healthcare and life sciences sectors with no immediate sector-wide shifts.

Minimal; no regional economic changes indicated.

Negligible; the news pertains to a specific company's quarterly results.

Counterpoint

The neutral tone suggests limited upside; some investors may prefer to wait for more definitive catalysts before acting.

Key entities

  • Aric Coffman

    Chief Executive Officer of P3 Health.

Related articles

$PIIIHigh

P3 Health Partners Inc. (PIII): Results of Operations and Financial Condition

P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 piii-20260810xexx991.htm EX-99.1 Document Exhibit 99.1 P3 Health Partners Announces Second Quarter 2026 Results Raises Full-Year 2026 Adjusted EBITDA Guidance Management to Host Conference Call and Webcast August 10, 2026 at 4:30 PM ET HENDERSON, NV—August 10, 2026—P3 H

$PIIIMedAI 8/10

Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Rises By 293.3%

P3 Health Partners (NASDAQ:PIII) reported short interest of 283,541 shares as of May 15, up 293.3% from 72,094 on April 30; about 4.8% of shares are sold short, with a days-to-cover ratio near 0.0. The stock fell 26% on Friday to $12.18. UBS and Lake Street set $14 targets; TD Cowen reiterated hold. The company reported Q1 EPS of $0.32 on revenue of $386.39M.

$QTTBMedAI 9/10

Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX

Biotech stocks rose on varied catalysts. Q32 Bio (QTTB) jumped 85% after a $55M private placement at $8.00/share; topline SIGNAL-AA Phase 2a Part B data are expected mid-2026. Soligenix (SNGX) gained 69% as it evaluates ThermoVax for Bundibugyo Ebola. Guardant (GH) rose 6% after ACS added its Shield blood test to updated colorectal screening guidelines; Q1 revenue was $301.7M (+48%).

$LNTMedAI 8/10

ONGC awards offshore contracts to L&T Energy Hydrocarbon Offshore

Larsen & Toubro’s subsidiary L&T Energy Hydrocarbon Offshore (LTEH Offshore) won offshore contracts from Oil & Natural Gas Corporation (ONGC) for India’s western coast. The awards cover ONGC’s Pipeline Replacement Project (PRP-X) and construction of four wellhead platforms. L&T said combined contract value is INR 50-100 billion (about $525.2m-$1.05b).

$LMTMedAI 8/10

Lockheed Martin Awarded Combat Systems Contract for Australian Submarines

According to Australia’s Submarine Agency, it awarded Lockheed Martin a two-year AUD 26.5 million (USD 18.7 million) contract to develop a sovereign Combat Systems Integration capability for Australia’s future Virginia-class submarines under AUKUS. The work includes U.S.-based subject-matter support and a market analysis of Australia’s supply-chain needs for local suppliers.

$BKRMed

Baker Hughes to Supply Subsea Systems for Kutei Northern Hub

Baker Hughes said it won a contract to supply subsea production systems and digital solutions for the Kutei Northern Hub offshore Indonesia. The deal with Searah North Ganal, a subsidiary of Searah Limited (JV of Eni and Petronas), covers 17 deepwater horizontal tree systems plus manifolds, control and distribution equipment, and Cordant asset protection and condition monitoring.